Introducing immunosuppressive or biological therapies early in people with Sjögren’s syndrome may prevent its progression to a bodywide systemic condition, a study in France suggests. “In our study, we can see that the introduction of [immunosuppressive agents] or biotherapy in systemic forms is only effective in around 50% of…
News
Older age, smoking, and a condition called Raynaud’s phenomenon are risk factors for developing interstitial lung disease (ILD) among people with primary Sjögren’s syndrome, according to a recent study. The study, “Interstitial lung disease and associated factors in patients with Sjögren’s syndrome,” was published in the…
To help shed light on what it’s like to live with Sjögren’s syndrome, a systemic autoimmune condition thought to affect about 4 million U.S. residents, this year’s Sjogren’s Awareness Month will focus on stories from the patients themselves. The annual April event is designed to showcase the disorder and…
Patients with primary Sjögren’s syndrome who have extra-glandular symptoms have higher levels of the chemokine CXCL9 than those only affected in the saliva and tear-producing glands, a study finds. CXCL9 is a small signaling molecule involved in the migration and maturation of lymphocytes, a type of immune cell thought…
The incidence of breast cancer is higher in women with primary Sjögren’s syndrome than the general population, a study from Taiwan indicates. Diabetes and high levels of anti-SSA autoantibodies were associated with a higher risk of developing breast cancer, according to “…
In adults with Sjögren’s syndrome with missing teeth, implant-supported overdentures — which are removable dentures that rest on implants — may improve the ability to chew, potentially leading to better quality of life, a study has found. The study, “Implant supported overdentures in Sjögren’s disease patients: a multicentre…
Autologous serum and platelet-rich eye drops work equally well to relieve dry eyes in people with primary Sjögren’s syndrome, but the latter may be more convenient because they take less time to prepare, a study suggests. The study, “Efficacy and safety of platelet-rich plasma and autologous-serum eye drops…
A Regenstrief Institute research scientist will use a five-year, $4.7 million federal grant on a Sjögren’s syndrome biomarker research project and dental training program aimed at fostering collaboration among healthcare professionals and incorporating into clinical practice research on disorders that affect oral health. Specifically, the grant from the National…
People with Sjögren’s syndrome who’ve had it for fewer than three years or whose disease is more active are at a higher risk of developing lupus, according to a study in Korea. Other factors linked to a higher lupus risk included a low number of white blood cells,…
Injecting the salivary glands with stem cells derived from fatty tissue was shown to ease the symptoms of Sjögren’s syndrome in a small clinical trial. “[Stem cell] therapy can provide relief of oral and eye’s dryness in our trial in a short time and has potential improvement of subjective…
Recent Posts
- Childhood-onset Sjögren’s can cause lasting damage to organs: Study
- Salivary duct treatment eases dry mouth in Sjögren’s disease: Study
- 4 genes linked to inflammatory cell death very active in Sjögren’s
- AI can see what doctors miss to accurately diagnose Sjögren’s
- Worse fatigue tied to more pain in people with Sjögren’s, study finds
- Dazodalibep therapy now in Phase 3 testing for Sjögren’s disease
- Sjögren’s treatment ianalumab shows rapid disease relief in trials
- Sjögren’s patients on nipocalimab report less pain, dryness in trial
- Ouro starts Phase 1b trial of OM336 for Sjögren’s disease treatment
- Telitacicept eases Sjögren’s disease activity in Phase 3 trial